Merkel Cell Carcinoma: A Complete Response to Avelumab Immunotherapy

Clinical Case Reports 2026 Open access

Read full text
Authors: Eamonn Byrne, Mel Corbett, Eoin T. Conlon, Fergal O’Duffy
DOI: 10.1002/ccr3.71768
Cited by: 0
References: 12

Abstract

Merkel cell carcinoma is an aggressive form of cancer with poor prognosis, particularly for individuals deemed unsuitable for surgical resection. With new immunotherapy agents being used alone or as an adjuvant treatment, improving long term outcomes are being seen, even for those deemed to be treated with palliative intent.

Fields of Study & Subjects

Polyomavirus and related diseases Nonmelanoma Skin Cancer Studies Viral-associated cancers and disorders

Publication details

Journal / source
Clinical Case Reports
Volume
14
Issue
2
Pages
e71768–e71768
Publication date
1 February 2026
Language
EN